Research is conflicted on whether whey protein helps improve cholesterol levels. Read what the studies say about whey protein ...
Scientists are digging into the ways dairy proteins affect metabolic and cardiovascular systems — with results that might ...
Natural products industry companies share overviews on the latest science on their dietary supplement branded ingredients and ...
What Is Redemplo, and Why Does It Matter? Redemplo (plozasiran) is a type of medicine called a small interfering RNA (siRNA) therapy approved to help lower extremely high triglyceride levels in adults ...
Plozasiran is the first FDA-approved drug for familial chylomicronemia syndrome, reducing triglycerides as an adjunct to diet. The phase 3 PALISADE trial showed significant triglyceride reduction with ...
In a world-first trial, scientists used a one-off CRISPR gene edit to switch off a liver “fat brake” gene, slashing stubborn LDL cholesterol and triglycerides in patients whose levels refused to budge ...
In a small, short-term, Phase 2 clinical trial in adults, a first-of-its-kind medication reduced triglyceride levels in most patients by more than 60%. Called DR10624, the medication activates three ...
Please provide your email address to receive an email when new articles are posted on . Olezarsen reduced triglycerides and the rate of acute pancreatitis events in patients with severely elevated ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Ionis Pharmaceuticals reported on Tuesday that a drug approved for a rare disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results